# OnCo record sattva-neelapu (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/sattva-neelapu/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "sattva-neelapu" ;
  schema:name "Sattva S. Neelapu"@en ;
  schema:description "Led ZUMA-1, the trial that made axicabtagene ciloleucel the first CAR-T therapy approved for lymphoma."@en ;
  schema:url <https://onco.cc/people/sattva-neelapu/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Neelapu%20SS%5BAuthor%5D%20axicabtagene> ;
  onco:tag "lymphoma", "car-t", "cell-therapy" ;
  schema:jobTitle "Professor and Deputy Chair, Department of Lymphoma and Myeloma, MD Anderson Cancer Center" ;
  schema:sameAs <https://orcid.org/0000-0003-1045-4914> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/axicabtagene-ciloleucel/> ;
  onco:institutions <https://onco.cc/institutions/md-anderson/> ;
  onco:trials <https://onco.cc/trials/zuma-7/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-zuma-1-axi-cel-nejm-2017/> ;
  onco:journals <https://onco.cc/journals/nature-reviews-clinical-oncology/> ;
  schema:affiliation <https://onco.cc/institutions/md-anderson/> .